Effect of dezocine and butorphanol tartrate self controlled intravenous analgesia pump on postoperative patients under general anesthesia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042982

Enrollment

Unknown

Registered

2021-02-03

Start date

2021-02-02

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

A:dezocine PCA

B:butorphanol PCA

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. ASA I or II subjects; 2. Subjects aged 18-70 years; 3. Subjects after general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular disease; 2. Patients with respiratory diseases, such as chronic bronchitis, asthma, respiratory tract infection in recent 2 weeks; 3. Subjects with long-term use of steroids or bronchodilators and ACEI drugs; 4. Patients with neurological and mental diseases.

Design outcomes

Primary

Measure	Time frame
VAS1h;VAS1d;VAS2d;Number of dizziness, nausea and vomiting;	—

Countries

China

Contacts

Public ContactGong Yuan

Yichang Central People's Hospital

gy-yc@163.com+86 13986746821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026